Learn more about our Supply Chain work.
The investments being made in our domestic semiconductor chip manufacturing base under the CHIPS and Science Act are critical for the medtech industry and the millions of patients who rely…
In a new op-ed in RealClear Health, AdvaMed President and CEO Scott Whitaker called on the Biden Administration to ensure the medtech industry is considered as it implements policies to…
Today, AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the recent actions to strengthen supply chains announced by President Biden as part of…
The 17th edition of EY’s Pulse of the Industry report offers a chance to take stock of the US and European medtech industry’s performance in 2023.
Today, AdvaMed marked the one year anniversary of the signing of the bipartisan CHIPS and Science Act and called on the Biden Administration to ensure, as implementation moves forward, that…
AdvaMed, the Medtech Association, today released a white paper recommending six priority areas including public-private partnerships, facilitating transportation, and supportive policies for building medical technology supply chain resilience.
This week, the Advanced Medical Technology Association (AdvaMed), the world’s largest trade association representing medical device manufacturers submitted recommendations to prioritize patient care as the National Institute of Standards and Technology (NIST)…
The Advanced Medical Technology Association (AdvaMed), the world’s largest trade association representing medical device manufacturers, applauded the United States House of Representatives and Senate for coming together to pass the…
Scott Whitaker, President and CEO of the Advanced Medical Technology Association (AdvaMed) thanked bipartisan leaders in the Senate for their work to pass the CHIPS Act, a bill that includes…
Mick Farrell, CEO of ResMed, joined Scott Whitaker on the Medtech POV podcast to explain what motivates him to serve patients and his community.